Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Jansen

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Cancer Care|July 5, 2021
Family history of cancer in first degree relatives and risk of cancer of unknown primaryAlexander L R Grewcock, Karlijn E P E Hermans, Matty P Weijenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancerJeroen Buijsen, Guido Lammering, Rob L H Jansen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2015
A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancerJeroen Buijsen, Jørgen van den Bogaard, Barry Jutten, et al.
Diseases of the Colon and Rectum|June 17, 2010
MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excisionSanne M E Engelen, Regina G H Beets-Tan, Max J Lahaye, et al.
Annals of Surgical Oncology|June 1, 2017
Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II StudyC Bisschop, T H van Dijk, J C Beukema, et al.
Annals of Surgical Oncology|March 7, 2013
Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastasesMaartje A J van den Broek, Celien P H Vreuls, Ali Winstanley, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastasesRonald M van Dam, Toine M Lodewick, Maartje A J van den Broek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancerMonique Maas, Regina G H Beets-Tan, Doenja M J Lambregts, et al.
Acta Oncologica (Stockholm, Sweden)|April 24, 2013
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)Sander Kelderman, Monique K van der Kooij, Alfons J M van den Eertwegh, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Cancer Care|July 5, 2021
Family history of cancer in first degree relatives and risk of cancer of unknown primaryAlexander L R Grewcock, Karlijn E P E Hermans, Matty P Weijenberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancerJeroen Buijsen, Guido Lammering, Rob L H Jansen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2003
High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal GroupJ Wils, G H Blijham, Th Wagener, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 9, 2015
A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancerJeroen Buijsen, Jørgen van den Bogaard, Barry Jutten, et al.
Diseases of the Colon and Rectum|June 17, 2010
MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excisionSanne M E Engelen, Regina G H Beets-Tan, Max J Lahaye, et al.
Annals of Surgical Oncology|June 1, 2017
Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II StudyC Bisschop, T H van Dijk, J C Beukema, et al.
Annals of Surgical Oncology|March 7, 2013
Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastasesMaartje A J van den Broek, Celien P H Vreuls, Ali Winstanley, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastasesRonald M van Dam, Toine M Lodewick, Maartje A J van den Broek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancerMonique Maas, Regina G H Beets-Tan, Doenja M J Lambregts, et al.
Acta Oncologica (Stockholm, Sweden)|April 24, 2013
Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)Sander Kelderman, Monique K van der Kooij, Alfons J M van den Eertwegh, et al.
Pageof 5